A 4-Week Pelvic Floor Muscle Training Program in Female Medical Students: Knowledge and Ultrasound Assessment

NCT07742072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2026-08-03

No results posted yet for this study

Summary

The aim of this study was to evaluate the effects of a four-week pelvic floor muscle (PFM) training program using different activation strategies on pelvic floor muscle function in healthy women. An additional objective was to assess participants' knowledge of pelvic floor muscle anatomy, function, and voluntary activation.

Healthy female medical students were assigned to one of three training groups: a breathing exercise group, an isolated pelvic floor muscle contraction group, or a combined pelvic floor muscle contraction with breathing group. The training program lasted four weeks. Pelvic floor muscle function was assessed before and after the intervention using transabdominal ultrasound imaging. Prior to the intervention, participants completed an author-developed questionnaire assessing their knowledge of pelvic floor muscles.

Conditions

  • Pelvic Floor Disorder
  • Pelvic Floor Awareness
  • Pelvic Floor Muscle Weakness

Interventions

BEHAVIORAL

Breathing exercises

Participants performed breathing exercises for four weeks. The training focused on diaphragmatic breathing and improving coordination between respiratory patterns and pelvic floor muscle function. Participants received instructions on proper breathing technique and performed exercises regularly according to the study protocol.

BEHAVIORAL

Pelvic floor muscle contraction training

Participants performed isolated voluntary pelvic floor muscle contractions for four weeks. The training focused on conscious activation and strengthening of the pelvic floor muscles. Participants received instructions on correct pelvic floor muscle contraction technique and performed exercises regularly according to the study protocol.

Sponsors & Collaborators

  • Medical University of Gdansk

    lead OTHER

Principal Investigators

  • Elżbieta Rajkowska-Labon, PhD · Medical University od Gdańsk

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
28 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-14
Primary Completion
2025-12-16
Completion
2025-12-16

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07742072 on ClinicalTrials.gov